Kevin Kit Parker, PhD

TissueNetix combines expertise in microfabrication, cellular biology and medical knowledge to develop next generation assays for drug screening and academic research. The goal of the company is to help scientists make better and quicker decisions based on cellular biology that accurately predicts what goes on in the human body.

Kit Parker

Tarr Family Professor of Bioengineering and Applied Physics
School of Engineering and Applied Sciences, Harvard University
Core Faculty Member, Wyss Institute for Biologically Inspired Engineering

Kit Parker researches cardiac cell biology and tissue engineering, traumatic brain injury, and biological applications of micro- and nanotechnologies. He is involved in projects ranging from creating organs-on-chips to developing nanofabrics for applications in tissue regeneration. Through funding from the National Institutes of Health and the U.S. Food and Drug Administration, he is currently helping develop a "heart-lung micromachine" that will accelerate drug safety and efficacy testing.

At the School of Engineering and Applied Sciences he is the director of the Disease Biophysics Group whose research focuses on mechanotransduction in neural and cardiovascular systems. He is also a member of the Systems Biology Program at Harvard Medical School, the Harvard Stem Cell Institute, and the Harvard-MIT Health Sciences and Technology Program.